XML 105 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash provided (required) by operating activities    
Net income (loss) $ (3,245.7) $ 19.8
Adjustments to reconcile net income to cash provided (required) by operating activities    
Depreciation 89.5 88.9
Amortization 30.9 30.5
Impairments 3,188.0 0.9
Employee benefit plan and share-based compensation costs 18.3 20.9
Deferred income tax provision (benefit), net (54.3) (90.8)
Unrealized loss on derivative instruments and foreign exchange 105.6 29.2
Income from equity affiliates, net of dividends received (25.4) (9.9)
Other 47.2 72.7
Changes in operating assets and liabilities, net of effects of acquisitions    
Trade receivables, net and contract assets (50.5) 131.8
Inventories, net (30.2) (61.5)
Accounts payable, trade (4.2) (148.6)
Contract liabilities 181.5 186.1
Income taxes payable (receivable), net 34.0 20.8
Other current assets and liabilities, net (375.2) (126.3)
Other noncurrent assets and liabilities, net 118.4 (43.1)
Cash provided by operating activities 27.9 121.4
Cash provided (required) by investing activities    
Capital expenditures (83.5) (178.2)
Payment to acquire debt securities   59.7
Cash received from divestiture 2.5  
Proceeds from sale of assets 7.5 0.9
Cash required by investing activities (73.5) (237.0)
Cash required by financing activities    
Net increase in short-term debt 87.0 114.5
Net decrease in commercial paper (578.5) (450.4)
Proceeds from revolving credit facility 500.0  
Proceeds from issuance of long-term debt   96.2
Purchase of ordinary shares   (33.0)
Payments related to taxes withheld on share-based compensation (3.2)  
Settlements of mandatorily redeemable financial liability (4.2) (174.9)
Cash provided (required) by financing activities 1.1 (447.6)
Effect of changes in foreign exchange rates on cash and cash equivalents (146.3) (11.5)
Decrease in cash and cash equivalents (190.8) (574.7)
Cash and cash equivalents, beginning of period 5,190.2 5,540.0
Cash and cash equivalents, end of period $ 4,999.4 $ 4,965.3